Matrix Partners has raised $300 million for its third India-focused venture capital fund, which will back companies in sectors including consumer and enterprise technology and financial technology.
Boulevard Capital Partners, a private equity investor focused on infrastructure including telecom towers, has agreed to invest $20 million in Singapore-listed surveillance technology specialist Stratech.
Indian automotive and aerospace parts manufacturer Sansera Engineering has filed for an IPO that will provide a partial exit for its private equity backer The Rohatyn Group (TRG).
Sen Do Technology (Sendo), a Vietnamese e-commerce company that operates a C2C platform and payment service, has secured $51 million in Series B funding led by Japan’s SBI Group.
Thunder Stone Technology, a Chinese karaoke equipment producer, has received nearly RMB200 million ($29 million) in Series B funding led by China Minsheng Investment Group.
Chinese online pharmacy operator 111 Inc, which counts ClearVue Partners, Verlinvest and BioVeda Capital among its investors, has filed for an IPO in the US.
The Blackstone Group has agreed to invest $400 million in YiChang HEC Changjiang Pharmaceutical (HEC Pharm), a Chinese drug developer listed in Hong Kong, through a convertible bond issuance.
Silicon Valley-based seed-stage accelerator Y Combinator (YC) has chosen Qi Lu, the former group president and COO of search giant Baidu, as the founding CEO of its China branch, YC China.
Singapore’s Golden Equator has launched an accelerator in Brunei aimed at helping local small to medium-sized enterprises (SME) expand across Southeast Asia.
Clobotics, a China and US-based computer vision start-up backed by a number of venture capital firms, has raised $11 million in Series A funding.
Japan’s Line Corporation has set up a $10 million fund via a Korean subsidiary that will make token investments in early-stage blockchain start-ups.
Sino-US venture capital firm GGV Capital is targeting $1.88 billion for its latest fund, which like its previous fund is grouped into four separate vehicles.
Green Investment Group (GIG), a global clean energy investment platform managed by Macquarie Capital, has acquired Conergy Asia & ME, a Singapore-based solar power developer owned by Goldman Sachs Asset Management and Tennenbaum Capital Partners.
Nexus Venture Partners has led an $8 million Series A funding round for Observe.AI, a business process outsourcing (BPO) services provider based in the US and India.
China’s Nio, an electric vehicle (EV) maker backed by a number of private equity firms, has filed for an IPO on the New York Stock Exchange that is expected to be the largest US listing for a Chinese car company to date.
Southeast Asia-focused VC firm Openspace Ventures – best known for being the first institutional investor in Indonesian ride-hailing and delivery platform Go-Jek – has closed its second fund at the hard cap of $135 million.
Crescendo Equity Partners, a mid-market Korean GP that concentrates on the industrial technology space, has closed its second fund at the hard cap of KRW450 billion ($398 million).
Indian dairy firm Dodla Dairy has filed for an IPO that will provide a partial exit for its private equity backer TPG Growth, the growth investment arm of TPG Capital.
MyDreamPlus, a Beijing-based co-working space provider, has raised $120 million in Series C funding led by General Atlantic (GA) and Hillhouse Capital.
IDG Capital has led a $20 million investment in Taiwan-based blockchain technology developer Dexon Foundation.
China International Capital Corp (CICC) has led a RMB300 million ($44 million) Series B funding round for Chinese commercial space industry start-up One Space.
Wattle Hill RHC, a private equity firm that targets Australian businesses with products and services that appeal to Chinese consumers, has won board approval for a A$189.7 million ($138 million) privatization of honey producer Capilano Honey.
KKR has agreed to buy a 60% stake in India-based environmental services provider Ramky Enviro Engineers (REEL) for $530 million via a combination of primary and secondary investments valuing the company at $925 million.
True North has agreed to acquire the Indian orthopedics and pain management business of drug maker Glenmark Pharmaceuticals at a valuation of INR6.4 billion ($91.8 million).